Author: Thomas Rabaut

IP + Health, Patents, Trade Secrets

You Paid for That Vaccine. So Why Can’t the World Afford It?

The COVID-19 pandemic exposed an uncomfortable truth: when American taxpayers fund the science behind life-saving medicines, private companies still get to decide who can afford them. When Moderna developed its groundbreaking mRNA COVID vaccine, it did so on the back of decades of government-funded research and over $1 billion in federal grants from the National Institutes of Health (“NIH”). Taxpayers funded the science. But when … Continue reading You Paid for That Vaccine. So Why Can’t the World Afford It?

Thomas Rabaut
Why Loyola

IP is Everywhere: How Loyola Helped Me Capitalize on My Early Interactions with Intellectual Property

When I read my first invention disclosure, an inventor’s confidential technical report describing a new invention, I believed I was conducting technical due diligence. After all, I was an engineering intern. I didn’t think I would be studying any legal doctrine. Well, it turned out I was doing both. The job was simple. Evaluate novelty. Functionality. Real-world value. Looking back now, I see that I … Continue reading IP is Everywhere: How Loyola Helped Me Capitalize on My Early Interactions with Intellectual Property

Thomas Rabaut